Skip to main content
. 2004 Jul;48(7):2448–2454. doi: 10.1128/AAC.48.7.2448-2454.2004

FIG. 6.

FIG. 6.

Evaluation of BMS-433771 treatment of BALB/c mice for therapeutic efficacy against RSV infection. Mice were treated with a single oral dose of BMS-433771 at 50 mg/kg 1 h before (−1 h) RSV inoculation, 5 min before (−5 min), or 1 h after (+1 h) RSV inoculation. Mice were inoculated intranasally with the Long strain of RSV. Symbols and lines are as defined in the legend to Fig. 1.